RxDoctor Payments Data

Douglas Miyazaki, MD

Obstetrics & Gynecology · Winston Salem, NCNPI 1053352435

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.3%), consulting fees and education — rather than concentrated in one kind of arrangement. Coloplast accounts for 72.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $7,182 and has fallen 92.1% since, to $566 in 2025. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,972in general payments, 2019–2025

Across 86 payments — averaging $162.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$10K
  • Axonics, Inc.$3K
  • Boston Scientific$389
  • Medtronic$238
  • SWAN Valley Medical Incorporated$196
  • Pacira Pharmaceuticals Incorporated$139
  • plus $211 from 4 others

What the payments were for

  • Consulting fees$5,44039%
  • Travel & lodging$9036%
  • Food & beverage$5,62940%
  • Education$2,00014%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,972 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.

See all obstetrics & gynecology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$58,950
Medicare patients
137
Services billed
1,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron114$91,021
GemtesaVibegron111$86,901
PremarinEstrogens, Conjugated133$63,831
Estradiol111$7,103
Solifenacin Succinate236$6,282
Fesoterodine Fumarate ErFesoterodine Fumarate19$2,424
Trospium Chloride32$1,857
Methenamine Hippurate32$1,543
Tolterodine Tartrate ErTolterodine Tartrate17$1,077
Tolterodine Tartrate19$775
Clobetasol Propionate17$472
Oxybutynin Chloride ErOxybutynin Chloride21$374
Ciprofloxacin Hcl47$312
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst22$299
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim57$215

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Winston Salem

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →